Granules India
Logotype for Granules India Limited

Granules India (532482) investor relations material

Granules India Q3 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Granules India Limited
Q3 25/26 earnings summary23 Jan, 2026

Executive summary

  • Q3 FY26 delivered strong operational and financial results, with revenue up 22% year-over-year and 7% sequentially, driven by Finished Dosage sales in North America and Europe, despite a temporary loss in the IT CDMO business.

  • EBITDA margin improved to 22.2% from 20.2% year-over-year, with EBITDA at INR 3,081 million, despite a ₹248 Mn EBITDA loss from Ascelis Peptides.

  • ROCE increased to 16.8% from 16.2% sequentially, with cash flow from operations at INR 2,187 million.

  • R&D expenses were INR 689 million (5% of sales), supporting long-term growth and 94 regulatory approvals to date.

  • Achieved highest “A” rating in climate change from CDP, S&P CSA score up to 62, and credit rating upgrade to AA.

Financial highlights

  • Q3 FY26 consolidated revenue reached INR 13,879 million, up 22% year-over-year and 7% sequentially.

  • Gross margin improved to 63.9%, up 216 bps year-over-year, though down 183 bps sequentially.

  • EBITDA was INR 3,081 million (22.2% of sales), up from INR 2,303 million (20.2%) in Q3 FY25.

  • PAT at INR 1,759 million, up 28% year-over-year; consolidated Q3 net profit at INR 1,502.11 million, up from INR 1,176.03 million YoY.

  • Cash flow from operations: INR 2,187 million; CapEx: INR 1,298 million in Q3.

Outlook and guidance

  • Q4 is expected to see meaningful improvement in peptide CDMO performance, with visibility for positive EBITDA.

  • Sequential improvement in sales and margins anticipated, driven by operational leverage and new launches.

  • U.S. revenue growth of $40–50 million annually is targeted to continue.

  • Remediation plan underway at Gagillapur facility following USFDA warning letter, with production and distribution paused and expected to impact near-term revenue and expenses.

  • Ongoing investments in R&D and new product launches to drive future growth.

Gagillapur remediation timeline
Capital raise fund utilization plans
New acquisitions' strategic contribution
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Granules India earnings date

Logotype for Granules India Limited
Q4 25/2615 May, 2026
Granules India
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Granules India earnings date

Logotype for Granules India Limited
Q4 25/2615 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Granules India Limited is a pharmaceutical company engaged in the manufacturing and distribution of active pharmaceutical ingredients (APIs), pharmaceutical formulations intermediates (PFIs), and finished dosage forms (FDFs). The company serves global pharmaceutical markets, supplying essential medicines across therapeutic categories such as pain management, cardiovascular, and anti-infectives. The company operates manufacturing facilities in India and internationally. It is headquartered in Hyderabad, India, and its shares are listed on the BSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage